Mixed Data For Bluebird's LentiGlobin, But Conditional Approval On The Cards

 
• By Lucie Ellis-Taitt
  
Blood sample
Bluebird looks towards 2017 EU conditional approval for LentiGlobin as beta-thalassemia gene therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapeutic Category